Manufacturer record
Elfin Drugs Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Elfin Drugs Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between November 2019 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ED24290, Telmisartan Tablets IP 40 mg (exp Aug 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample is declared to be Not of Standard Quality for the reason stated under Description. Listed in the November 2025 alert.
Records by type
6 records linked to Elfin Drugs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40 mg | Batch ED24290Mfg Sep 2024 · Exp Aug 2026 | The sample is declared to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab | Nov 2025 |
| Telmisartan Tablets IP 40 mg | Batch ED25088Mfg Jul 2025 · Exp Jun 2027 | The sample is declared to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab | Nov 2025 |
| Metformin Hydrochloride Tablets IP(Elmet-500) | Batch G-358/5431Mfg Dec 2023 · Exp Nov 2025 | The sample does not conform to IP with respect to test for DescriptionDescription | SDTL, JharkhandState lab | Jul 2025 |
| ELTHROM-200 (Azithromycin oral suspension IP) 15ML | Batch G-042/5045Mfg May 2023 · Exp Apr 2025 | CONTENT OF AZITHROMYCIN IN THE SAMPLE IS LESS (72.96% OF LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT-90.0%- 110.0%)Labelling | State Lab MaharashtraState lab | Jun 2024 |
| Romavit Capsules (Amino Acids, Biotin, Folic Acid, Vitamins and Minerals Capsules) | Batch K22CS-36Mfg May 2022 · Exp Oct 2023 | Description, Assay of N-Acetyl CysteineAssay | CDL KolkataCDSCO lab | Jan 2023 |
| Albendazole Tablets I.P. (C-Bend) | Batch G002/2561Mfg Apr 2019 · Exp Mar 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.